Cobalt sulfate hydrate, gallium arsenide, molybdenum trioxide, vanadium pentoxide, and nickel sulfate heptahydrate were tested in the Syrian hamster embryo (SHE) assay in order to increase the SHE assay database for heavy metals. All five compounds produced significant morphological transformation at one or more doses in a dose-responsive manner. Cobalt sulfate hydrate, gallium arsenide, molybdenum trioxide, and nickel (IT) sulfate heptahydrate were all positive with a 24-hr exposure, suggesting direct DNA perturbation. Vanadium pentoxide was negative with a 24-hr exposure, but positive with a 7-day exposure. This pattern of response (24-hr SHE negative/7-day SHE positive) has been seen with other chemicals which have tumor promotion-like characteristics. Since the inception of the use of the SHE cell transformation assay for detecting the neoplastic transformation potential of chemicals, over 42 heavy metal compounds have been tested in this assay. Based on the 24 metal compounds which have been tested in the SHE, Salmonella, and some type of rodent bioassay, the SHE assay is 92% concordant with rodent bioassay carcinogenicity results, including a sensitivity of 95% (21/22) and a specificity of 50% (1/2). At this time, the measure of SHE assay specificity for rodent carcinogenicity of metals is limited by the paucity of metal compounds which are rodent noncarcinogens. The Salmonella assay results are only 33% concordant with the rodent bioassay for these same chemicals. This relatively high concordance between the SHE assay and the rodent bioassay carcinogenicity results demonstrates the utility of the SHE assay for determining the carcinogenic potential of heavy metal compounds in rodent Cancer bioaSSays. C 1996 Soday of Toxicology.
In 1963 Berwald and Sachs described the in vitro morphological transformation of normal Syrian hamster embryo cells to tumor cells by carcinogenic chemicals (Berwald and Sachs, 1963) . Since that time the Syrian hamster embryo (SHE) cell in vitro transformation assay has been used by numerous investigators to test the transforming potential of over 472 chemical/physical agents. Of these 472 chemicals, over 200 have been tested in the standard rodent bioassay, giving a sensitivity of 82% (146/177), a specificity of 69% (25/36), and an 80% concordance (171/213) between the results of these two tests. Using a modification of the original SHE assay protocol, which is principally a reduction in the culture medium pH from 7.3 to 6.7, we have tested 48 chemicals for their SHE cell transformation potential. The concordance between the reduced pH SHE assay and the rodent bioassay for these 48 chemicals is 85% (41/48), including a sensitivity of 87% (26/30) and a specificity of 83% (15/ 18). Importantly, although rodent noncarcinogens are fewer in number than rodent carcinogens, the SHE assay specificity for the rodent bioassay is greater than 80%.
The purpose of the present study was to test the transformation potential of five metal compounds: cobalt sulfate hydrate, gallium arsenide, molybdenum trioxide, nickel (II) sulfate heptahydrate, and vanadium pentoxide, using the reduced pH SHE transformation assay protocol in order to increase the SHE assay heavy metal database. SHE assay data, Salmonella assay data, and rodent carcinogenicity data from the literature on heavy metal compounds were used to determine the concordance between rodent carcinogenicity and SHE assay results and between rodent carcinogenicity and Salmonella assay results. Historically, the Salmonella assay has been a poor predictor of rodent carcinogenicity for heavy metals and heavy metal compounds (IARC Monograph No. 23, 1980, pp. 34-35.) , therefore leading us to evaluate other technologies for accurately determining the carcinogenic potential of heavy metal compounds. As we demonstrate in this report, the SHE transformation assay is a useful tool for the prediction of rodent carcinogenicity for heavy metal compounds.
MATERIALS AND METHODS
A comprehensive protocol for the conduct of the SHE transformation assay, under pH 6.7 culture conditions, has been published (Kerckaert et al., 1996) . Briefly, using cells isolated from 13-day-gestation embryos, a SHE cell cytotoxicity screen is done initially to determine a dose level that is at least 50% cytotoxic for each test chemical, as determined by a reduction in SHE cell colony plating efficiency over that of the solvent control. The cytoxicity is most important for fnorphologica] transformation (MT) negative compounds since it demonstrates biological activity in response Rodent carcinogenicity results and Salmonella assay results were obtained from the NTP carcinogenicity database (NTP Technical Reports, 1993) , the USEPA GENE-TOX database (Nesnow et al., 1986) , the IARC Carcinogen and Salmonella databases (IARC Monographs), the Gold database (Gold et al., 1984 (Gold et al., -1993 , and the NTP Salmonella database (Ashby and Tennant, 1988; Tennant et al., 1987; Zeiger et al., 1992 Zeiger et al., , 1990 Zeiger et al., , 1988 Zeiger et al., , 1987 Ishidate et a!., 1988) .
RESULTS
Our strategy for testing the heavy metal compounds in the SHE assay was to test each compound initially in a 24-hr-exposure regimen. If the test compound was negative in the 24-hr-exposure SHE assay, a second 7-day-exposure assay was performed. SHE transformation assay results for the five metal compounds are shown in Figs. 1 and 2.
Cobalt sulfate with culture medium as the solvent in a 24-hr exposure to SHE cells induced a significant increase in SHE cell MT at all doses tested from 0.125 to 1 fxg/m\, with 66% cytotoxicity achieved at the top dose. Although the trend test of the transformation frequency data set was not significantly positive {p = 0.0739), the overall SHE assay call for this compound is positive because of the significant transformation seen in at least two of the test chemical doses.
Gallium arsenide with DMSO as the solvent in a 24-hr exposure to SHE cells yielded a significant increase in SHE cell MT at all five doses from 0.5 to 1.5 /xg/ml, with the top dose achieving 71% cytotoxicity. The trend test result for this data set was significantly positive (p = 0.0000). Therefore, our overall SHE assay call for gallium arsenide is positive.
Molybdenum trioxide in a 24-hr exposure to SHE cells with culture medium as the solvent gave a significant increase in SHE cell MT in four doses 5=75 ^g/ml, while achieving 67% cytotoxicity at the top dose of 200 fig/m\ . The trend test result for this transformation frequency data set positive (p = 0.0006), resulting in an overall positive call for this chemical in the SHE assay.
Nickel sulfate heptahydrate with culture medium as the solvent in a 24-hr-exposure SHE assay resulted in a significant increase in SHE cell MT (p < 0.05) in the top four doses tested, while achieving 61% cytotoxicity. The trend test result for this transformation frequency data set was positive (p = 0.0031). Nickel sulfate heptahydrate with culture medium as the solvent in a 7-day exposure to SHE cells resulted in a significant increase in SHE cell MT (p < 0.05) in four of five doses tested, while achieving 67% cytotoxicity at 25 fig/ml. The trend test result for this transformation frequency data set was also significantly positive (p = 0.0002), resulting in an overall SHE assay positive call for nickel sulfate. Both 24-hr-and 7-day-exposure SHE assays were done with nickel sulfate to allow comparison to SHE results obtained for vanadium pentoxide.
With culture medium as the solvent in the 24-hr-exposure SHE transformation assay, vanadium pentoxide was negative for significant MT at all five doses tested, with 49% cytotoxicity achieved at the top dose of 0.75 fig/ml. The trend test result for the 24-hr-exposure transformation frequency data set was not significantly positive (p = 0.2771). In contrast, the 7-day-exposure SHE cell transformation assay yielded significant MT results at all five doses tested up to 0.875 /ig/ml, with this top dose achieving 43% cytotoxicity. The trend test result for this 7-day-exposure transformation frequency data set was significantly positive {p = 0.0000). Therefore, our overall call for vanadium pentoxide is SHE assay positive.
DISCUSSION
Analysis of the MT potential of five metal compounds tested in the reduced pH SHE assay demonstrates that three of five yielded significant MT at multiple doses of less than 1 /zg/ml, with molybdenum trioxide requiring a dose of at least 75 ^g/ml to demonstrate MT and nickel sulfate requiring a dose of 5 //g/ml to yield significant MT. This indicates the relatively high potency of metal compounds as a class for inducing MT. Interestingly, a continuous 7-day exposure was required for vanadium pentoxide to generate significant MT, as no significant MT was observed after a 24-hr-exposure at doses that caused up to 50% cytotoxicity. We have observed 7-day-exposure SHE assay positive/24-hr-exposure SHE assay negative results with other chemicals tested in the SHE assay (i.e., 12-O-tetradecanoylphorbol 13-acetate, butylbenzyl phthalate, methapyrilene, and diethylhexyl phthalate). The need for a continuous 7-day exposure to yield significant transformation could indicate that these chemicals are having a "promotion-like" effect on the SHE cells. In fact, vanadium pentoxide has been reported to act as an effector of signal transduction due to its tyrosine protein phosphatase inhibition properties and to act in a "promotional" manner following benzo[a]pyrene initiation in SHE cells (Rivedal et al, 1990) . In contrast, NiSO 4 was positive Coombs (1989 ) Mikalsen (1988 ) LeBoeuf (1996 ) Dunkel (1981 ) LeBoeuf (1996 ) Kerckaert (1996b ) Rivedal (1990 ) Rivedal (1990 ) LeBoeuf (1996 ) Rivedal (1981 ) Elias (1989 ) Suzuki (1987 ) Elias (1989 ' SHE assay conducted at pH 6.7.
for significant MT after both 24-hr-and 7-day-exposures, which is a typical SHE assay response for complete carcinogens. Trie other three metal compounds appear similar to nickel sulfate in that they are 24-hr-exposure SHE assay positive and probably reflect complete carcinogenicity.
Data for 42 metal compounds tested in the SHE assay since 1965, along with their Salmonella assay and rodent bioassay results, are shown in Table 1 . Here, the majority of the metal compounds are Salmonella assay negative (21/ 35) and SHE assay positive (36740). A summary of the data in Table 1 shows a comparison of SHE assay to rodent bioassay results and a comparison of Salmonella assay to rodent bioassay results for those metal compounds that have data common to all three tests (Table 2) . A comparison of SHE assay and bioassay results for these 24 compounds indicates a sensitivity of 95% (number of carcinogens correctly identified by the SHE assay, 21/22), a specificity of 50% (number of noncarcinogens correctly identified by the SHE assay, 1/2), and a concordance between these two assays of 92% (combined sensitivity and specificity, 22/24). The comparison of the Salmonella assay with the bioassay for these same 24 compounds indicates a sensitivity of 32%, a specificity of 50%, and a concordance of 33%. At this time, the measure of SHE assay specificity for rodent carcinogenicity of metals is limited by the paucity of heavy metal rodent noncarcinogens. Titanium dioxide is the one rodent carcinogen in Table 1 that was negative in the SHE assay. Importantly, titanium dioxide has been shown to be a rodent carcinogen only when dosed via an inhalation route, not when dosed orally, and only when a concentration exceeding the lung particle clearance ability is inhaled (Lee et al., 1985) . Titanocene dichloride is the one rodent noncarcinogen that was positive in the SHE assay. Actually, titanocene dichloride was classified as an equivocal carcinogen by the NTP (NTP Technical Report No. 399), based upon a marginal increase in forestomach squamous cell papillomas, squamous cell carcinoma, and benign basosquamous tumors in male F344/N rats. This compound injected intramuscularly in the rat has shown more clearcut evidence of tumorigenesis (NCI Progress Report No. 43) . Therefore the rodent carcinogenicity of titanocene dichloride is at present unclear and this chemical may prove to be a rodent carcinogen when evaluated by multiple mechanisms. However, for the comparisons in this paper, we classified all equivocal carcinogens as noncarcinogens.
In conclusion, the relatively high concordance between the SHE assay and the rodent bioassay (92%) combined with the relatively low concordance between the Salmonella assay and the rodent bioassay (33%) for the metals and metal compounds as a class recommends the use of the SHE assay for determining the carcinogenic potential of this class of compounds in rodent cancer bioassays.
